EV/EBITDA
-6.38
-0.02-0.31%
89 min ago
Summary
- As of February 7, 2025, DNLI EV/EBITDA is -6.38, with a fall of -0.02 (-0.31%) during the most recent trading day.
- Over the past year, DNLI EV/EBITDA has increased by +6.28 (+49.61%).
- DNLI EV/EBITDA is now -103.40% below its all-time high of 187.57.
Performance
DNLI EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
DNLI EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -0.3% | +0.4% | +0.4% |
| 1 m1 month | -5.1% | +5.0% | +5.0% |
| 3 m3 months | +25.0% | -25.1% | -24.8% |
| 6 m6 months | -0.9% | +2.8% | +2.6% |
| ytdytd | -9.3% | +9.3% | +9.2% |
| 1 y1 year | +49.6% | +38.8% | +30.8% |
| 5 y5 years | +50.2% | +20.3% | -11.3% |
DNLI EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -19.9% | -6.78 | +5.9% | |
| 3 m | 3-month | -5.26 | -21.3% | -9.09 | +29.8% |
| 6 m | 6-month | -5.26 | -21.3% | -9.09 | +29.8% |
| 1 y | 1-year | -5.26 | -21.3% | -17.64 | +63.8% |
| 3 y | 3-year | -5.26 | -21.3% | -29.56 | +78.4% |
| 5 y | 5-year | 187.57 | -103.4% | -47.42 | +86.5% |
| alltime | all time | 187.57 | -103.4% | -58.31 | +89.1% |
Denali Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -6.38(+9.2%) |
| 2024 | -5.84(-63.5%) |
| 2023 | -15.99(+45.8%) |
| 2022 | -10.97(-39.7%) |
| Date | Value |
|---|---|
| 2021 | -18.19(-113.4%) |
| 2020 | 135.54(-1767.2%) |
| 2019 | -8.13(-83.1%) |
| 2018 | -48.22(+265.0%) |
| 2017 | -13.21 |
FAQ
- What is Denali Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Denali Therapeutics?
- What is DNLI EV/EBITDA year-to-date change?
- What is Denali Therapeutics EV/EBITDA year-on-year change?
What is Denali Therapeutics EV/EBITDA?
The current EV/EBITDA of DNLI is -6.38
What is the all time high EV/EBITDA for Denali Therapeutics?
Denali Therapeutics all-time high EV/EBITDA is 187.57
What is DNLI EV/EBITDA year-to-date change?
Denali Therapeutics EV/EBITDA has changed by -0.54 (-9.25%) since the beginning of the year
What is Denali Therapeutics EV/EBITDA year-on-year change?
Over the past year, DNLI EV/EBITDA has changed by +6.28 (+49.61%)